Comparing thrombectomy and medical management for stroke patients treated after 24 hours

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of endovascular treatment (EVT) for patients with large vessel occlusion (LVO) who present more than 24 hours after stroke onset. It aims to determine if EVT can improve functional independence at 90 days compared to best medical management (BMM) in this delayed treatment group. Participants will undergo CT angiography to confirm LVO and assess collateral circulation before being randomized to receive either EVT or BMM. The study will follow participants for 90 days to evaluate their functional outcomes and safety profiles.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Confirmation of ICA or MCA-M1 occlusion, as detected by MRA or CTA, with carotid occlusions potentially occurring in either the cervical or intracranial regions, and the possibility of accompanying tandem MCA lesions.
2. Demonstration of moderate to good collateral flow, as evidenced by CTA imaging.
3. The patient must be aged 18 years or older.
4. The baseline NIHSSS score is equal to or greater than 2, and this score remains equal to or greater than 2 immediately prior to randomization.
5. Endovascular treatment can be initiated (via femoral puncture) within a window of 24 to 72 hours from the onset of the stroke. The onset of the stroke is defined as the time the patient was last known to be at their neurologic baseline (patients with wake-up strokes are eligible if they meet the aforementioned time constraints).
6. There must be no significant pre-stroke disability, as indicated by a pre-baseline modified Rankin Scale score of 0-2.
7. The patient must be willing and able to return for the protocol-required follow-up visits.
8. The patient or their legally authorized representative must have signed the Informed Consent form.

Exclusion Criteria:

1. The subject has a serious, advanced, or terminal illness (as determined by the investigator) or a life expectancy of less than six months.
2. The subject has a pre-existing medical, neurological, or psychiatric disease that would interfere with neurological or functional evaluations, or is already participating in another drug or device study.
3. The subject is pregnant.
4. The subject has contraindications for both MRI and CT contrast that prevent an MRI or CT contrast perfusion study. The hospital's local standard criteria should be applied to determine if contraindications exist.
5. The subject has a known allergy to iodine and has previously been refractory to pretreatment medications.
6. The subject has been treated with tPA more than 4.5 hours after the last known well time.
7. The subject has a known hereditary or acquired hemorrhagic diathesis, coagulation factor deficiency, or has recently undergone oral anticoagulant therapy with an INR greater than 3.
8. The subject has symptoms consistent with stroke in multiple locations.
9. The subject has seizures at stroke onset, which makes the diagnosis of stroke doubtful and precludes obtaining an accurate baseline NIHSS assessment.
10. The subject has a baseline blood glucose level of less than 50mg/dL (2.78 mmol) or greater than 400mg/dL (22.20 mmol).
11. The subject has a baseline platelet count of less than 50,000/uL.
12. The subject has severe, sustained hypertension (Systolic Blood Pressure \>185 mmHg or Diastolic Blood Pressure \>110 mmHg) that is not treatable with medications.
13. The subject is currently participating in another investigational drug or device study or registry.
14. The subject is presumed to have a septic embolus, suspicion of bacterial endocarditis, or cerebral vasculitis.
15. The subject has had clot retrieval attempted using a neurothrombectomy device within 24 hours of symptom onset.

Where it's running

• Tianjin Huanhu Hospital
  Tianjin, Tianjin Municipality, China Recruiting

Study contacts

• Study coordinator: Ming Wei, MD, PhD
• Email: drweiming@163.com
• Phone: 13502182903

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Intra-arterial Alteplase after successful reperfusion following mechanical thrombectomy

  This trial tests whether giving a small amount of alteplase directly into the artery after a successful thrombectomy helps adults with acute ischemic stroke recover better.

  Recruiting at 9 sites Phase 3 115 People's Hospital · An Giang and 12 other locations · NCT07727395

• Sivelestat added to endovascular clot retrieval for acute anterior circulation stroke

  This study tests whether giving sivelestat sodium alongside mechanical thrombectomy helps improve outcomes for adults with acute ischemic stroke due to large vessel occlusion.

  Recruiting at 2 sites Xuanwu Hospital, Beijing · Weifang, Shandong and 1 other locations · NCT07552610

• Injecting methylprednisolone into the artery right after clot removal for large-vessel stroke

  This trial will test whether giving methylprednisolone into the artery immediately after successful clot removal, followed by three days of IV methylprednisolone, helps adults with anterior large-vessel occlusion strokes recover better.

  Recruiting Phase 2 Tang-Du Hospital · Xi'an, Shaanxi · NCT07516522

• Effectiveness of a new neurorehabilitation technology for stroke recovery

  This study is testing a new rehabilitation technology that uses robots and virtual reality to see if it can help stroke patients recover better than regular therapy.

  Recruiting Neurotechnika · Samara, Samara Oblast · NCT06753006

• Using AI to speed up transfers for stroke patients needing thrombectomy

  This study tests if using an AI tool can help speed up the transfer of stroke patients to hospitals that can provide a special treatment called thrombectomy.

  Recruiting at 2 sites Hospital Universitari Vall d'Hebron Research Institute · Granollers, Barcelona and 1 other locations · NCT06741332

• Rescue stenting and thrombolysis for large vessel ischemic stroke

  This study tests if combining rescue stenting with a clot-busting treatment can help adults who have a severe stroke and didn't get better with standard procedures.

  Recruiting at 7 sites ASST Santi Paolo e Carlo · Bergamo, Italy and 6 other locations · NCT06727006

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.